Cantor Fitzgerald analyst Ross Osborn maintained a Buy rating on CVRx (CVRX – Research Report) yesterday and set a price target of $20.00. The company’s shares closed yesterday at $11.54.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Osborn is an analyst with an average return of -13.2% and a 25.36% success rate. Osborn covers the Healthcare sector, focusing on stocks such as CVRx, AxoGen, and NeuroPace.
CVRx has an analyst consensus of Strong Buy, with a price target consensus of $19.40, a 68.11% upside from current levels. In a report released today, Piper Sandler also maintained a Buy rating on the stock with a $20.00 price target.
CVRX market cap is currently $305.1M and has a P/E ratio of -4.28.
Read More on CVRX:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue